Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity

OBJECTIVE: Adoptive regulatory T cell (Treg) therapy is being trialled for the treatment of different autoimmune disorders, including inflammatory bowel diseases (IBD). In‐depth understanding of the biological variability of Treg in the human blood may be required to improve IBD immune monitoring an...

Descripción completa

Detalles Bibliográficos
Autores principales: Weerakoon, Harshi, Straube, Jasmin, Lineburg, Katie, Cooper, Leanne, Lane, Steven, Smith, Corey, Alabbas, Saleh, Begun, Jakob, Miles, John J, Hill, Michelle M, Lepletier, Ailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419695/
https://www.ncbi.nlm.nih.gov/pubmed/34504692
http://dx.doi.org/10.1002/cti2.1334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419695/
https://www.ncbi.nlm.nih.gov/pubmed/34504692
http://dx.doi.org/10.1002/cti2.1334

Ejemplares similares